PharmaEssentia Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24,175	22,693	21,051	19,666	10,304	3,454
Short-Term Investments	-	0.43	-	-	-	-
Cash & Short-Term Investments	24,175	22,693	21,051	19,666	10,304	3,454
Cash Growth	9.72%	7.80%	7.04%	90.86%	198.34%	7.51%
Accounts Receivable	4,777	4,472	2,624	1,312	798.87	466.04
Other Receivables	106.19	176.79	210.67	236.08	41.22	27.17
Receivables	4,883	4,649	2,834	1,548	840.09	493.22
Inventory	1,269	1,328	1,287	1,459	1,102	861.38
Prepaid Expenses	496.05	306.35	163.58	151.92	55.64	49.02
Other Current Assets	99.74	67.05	80.96	71.18	1,074	69.41
Total Current Assets	30,923	29,044	25,417	22,896	13,375	4,927
Property, Plant & Equipment	5,232	4,902	3,361	2,733	1,018	764.93
Long-Term Investments	428.48	461.44	542.44	163.92	43.24	39.22
Other Intangible Assets	224.26	235.12	272.72	267.91	236.88	246.25
Long-Term Deferred Tax Assets	1,941	1,693	1,120	958.46	483.42	-
Other Long-Term Assets	1,341	1,076	347.95	249.72	176.38	221.13
Total Assets	40,090	37,411	31,062	27,269	15,333	6,198
Accounts Payable	143.77	156.73	126.47	128.88	230.96	176.38
Accrued Expenses	1,144	1,736	1,106	970.52	667.45	405.5
Short-Term Debt	-	-	-	21	993.88	20
Current Portion of Long-Term Debt	5.98	5.98	11.9	12.36	12.14	12.05
Current Portion of Leases	186.21	202.31	180.56	211.85	77.76	78.59
Current Income Taxes Payable	667.32	266.54	-	0.99	-	-
Current Unearned Revenue	0.07	-	0.23	-	-	-
Other Current Liabilities	2,590	2,313	1,132	806.49	568.16	719.44
Total Current Liabilities	4,737	4,681	2,557	2,152	2,550	1,412
Long-Term Debt	43.34	44.83	50.81	62.71	74.98	87.09
Long-Term Leases	725.63	602.91	722.16	892.29	410.05	338.51
Pension & Post-Retirement Benefits	10.74	10.38	11.06	10.21	4.18	3.95
Long-Term Deferred Tax Liabilities	104.09	84.37	81.32	105.96	8.22	-
Other Long-Term Liabilities	14.29	12.76	170.21	97.91	143.64	106.3
Total Liabilities	5,635	5,436	3,593	3,321	3,191	1,948
Common Stock	3,799	3,796	3,418	3,403	3,025	2,769
Additional Paid-In Capital	24,107	24,106	23,547	24,092	13,421	4,697
Retained Earnings	9,394	7,244	2,974	-631.19	-4,186	-2,811
Treasury Stock	-2,718	-2,763	-2,805	-2,805	-87.5	-344.74
Comprehensive Income & Other	-127.91	-408.75	335.89	-110.37	-31.54	-60.15
Shareholders' Equity	34,454	31,975	27,469	23,948	12,141	4,250
Total Liabilities & Equity	40,090	37,411	31,062	27,269	15,333	6,198
Total Debt	961.16	856.03	965.43	1,200	1,569	536.24
Net Cash (Debt)	23,214	21,837	20,086	18,466	8,735	2,917
Net Cash Growth	10.29%	8.72%	8.77%	111.40%	199.41%	13.71%
Net Cash Per Share	62.48	58.84	54.19	51.60	27.70	10.10
Filing Date Shares Outstanding	371.63	371.16	369.42	367.72	334.64	303.03
Total Common Shares Outstanding	371.63	371.16	369.42	367.72	334.64	303.03
Working Capital	26,186	24,363	22,860	20,744	10,825	3,515
Book Value Per Share	92.71	86.15	74.36	65.13	36.28	14.03
Tangible Book Value	34,230	31,740	27,196	23,680	11,904	4,004
Tangible Book Value Per Share	92.11	85.52	73.62	64.40	35.57	13.21
Land	132.93	58.24	58.24	58.24	58.24	58.24
Buildings	69.82	69.82	70.86	70.63	70.61	70.52
Machinery	1,194	1,175	811.38	723.26	534.93	486.58
Construction In Progress	3,234	3,072	2,011	1,188	234.56	36.49
Leasehold Improvements	757.04	754.58	429.87	426.29	371.12	341.61